Search Results
Showing matching global market intelligence studies.
Sequencing Market
The global sequencing market was valued at USD 5.3 billion in 2025 and is projected to reach USD 8.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Sequencing Consumables Market
The global sequencing consumables market was valued at USD 2.7 billion in 2025 and is projected to reach USD 4.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Sepsis Therapeutics Market
The global sepsis therapeutics market was valued at USD 2.7 billion in 2025 and is projected to reach USD 4.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Sepsis Diagnostics Market
The global sepsis diagnostics market was valued at USD 3.3 billion in 2025 and is projected to reach USD 7.8 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Separation Systems for Commercial Biotechnology Market
The global separation systems for commercial biotechnology market was valued at USD 6.7 billion in 2025 and is projected to reach USD 13.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Sentinel Node Biopsy Market
The global sentinel node biopsy market was valued at USD 3.7 billion in 2025 and is projected to reach USD 8.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Sentinel Lymph Node Biopsy Imaging Agents Market
The global sentinel lymph node biopsy imaging agents market was valued at USD 3.9 billion in 2025 and is projected to reach USD 5.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Senolytics Anti-Aging Pharmaceuticals Market
The global senolytics anti-aging pharmaceuticals market was valued at USD 7.5 billion in 2025 and is projected to reach USD 16.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Semi-Solid Dosage Drugs Market
The global semi-solid dosage drugs market was valued at USD 4.5 billion in 2025 and is projected to reach USD 8.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Semi-Solid Dosage Contract Manufacturing Market
The global semi-solid dosage contract manufacturing market was valued at USD 1.5 billion in 2025 and is projected to reach USD 3.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Semi-Solid Dosage CDMO Market
The global semi-solid dosage cdmo market was valued at USD 5.9 billion in 2025 and is projected to reach USD 11.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Semaglutide Market
The global semaglutide market was valued at USD 4.9 billion in 2025 and is projected to reach USD 12.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Self-Testing Market
The global self-testing market was valued at USD 6.1 billion in 2025 and is projected to reach USD 9.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Self-Injection Devices Market
The global self-injection devices market was valued at USD 3.5 billion in 2025 and is projected to reach USD 8.4 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Self-Expanding Stents Market
The global self-expanding stents market was valued at USD 6.7 billion in 2025 and is projected to reach USD 17.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 13.1% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.